Alembic Pharmaceuticals Ltd
Yagnesh Patel is a Regulatory Affairs Executive with extensive experience in the pharmaceutical industry. Currently employed at Alembic Pharmaceuticals Limited since December 2023, Yagnesh has previously held similar positions at BDR Pharmaceuticals Int'l Pvt Ltd from January 2022 to December 2023, and at Intas Pharmaceuticals from July 2019 to January 2022. Yagnesh holds an M. Pharm degree in Pharmaceutical Regulatory Affairs from the Graduate School of Pharmacy, GTU, completed between 2017 and 2019, as well as a Bachelor of Pharmacy degree from Babaria Institute of Pharmacy, Varnama, earned from 2013 to 2017.
This person is not in any teams
This person is not in any offices
Alembic Pharmaceuticals Ltd
8 followers
Alembic Pharmaceuticals Limited is a pharmaceutical company. The Company is engaged developing formulations and active pharmaceutical ingredients (API). The Company focuses on anti-infective, analgesic and, cough and cold therapies. It also focuses on therapies, such as cardiology, diabetes, gynecology, gastrointestinal, orthopedic, dermatology and ophthalmology. Its APIs include independent manufacturing blocks for Macrolides, non-steroidal anti-inflammatory drugs (NSAIDs) and other drugs. The Company offers international and domestic formulations. Under domestic formulation, it offers Branded Formulations and Generic formulations. Its domestic formulation include Roxid, Zofix, Althrocin, Tellzy AH, Revas H, Lactonic, Folinal, Gestofit, Glisen 1/2, Glimser 1/2, Veldrop, Azithral, Brinzemic and Neolap. Its generic formulations include Cetral, Ephedrex CD, Sicor, Worid, Alcephin, Alcizon, Baciclox, Comeba, Furobid, O Win Suspension, O win T, Silomag Gel, Pentab, Aginal AT and Pyremol.